• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device system, test, carbohydrate antigen (ca19-9), for monitoring and management of pancreatic cancer
Definition An in vitro diagnostic test for the quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma. The test is intended as an aid in the management of patients with confirmed pancreatic cancer and serial monitoring of their response to therapy and disease progression. The test should only be used in patients with serum and plasma CA 19-9 values above the cut-off at the time of diagnosis and in conjunction with other clinical methods.
Product CodeNIG
Regulation Number 866.6010
Device Class 2


Premarket Reviews
ManufacturerDecision
FUJIREBIO DIAGNOSTICS, INC.
  SUBSTANTIALLY EQUIVALENT 1
FUJIREBIO DIANOSTICS, INC.
  SUBSTANTIALLY EQUIVALENT 1

MDR Year MDR Reports MDR Events
2017 98 98
2018 58 58
2019 135 135
2020 93 95
2021 69 69
2022 42 42

Device Problems MDRs with this Device Problem Events in those MDRs
High Test Results 329 331
No Apparent Adverse Event 50 50
Low Test Results 48 48
Incorrect Or Inadequate Test Results 31 31
Non Reproducible Results 27 27
Adverse Event Without Identified Device or Use Problem 16 16
High Readings 8 8
Off-Label Use 7 7
Incorrect, Inadequate or Imprecise Resultor Readings 4 4
Incorrect Measurement 3 3
False Positive Result 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Known Impact Or Consequence To Patient 298 300
No Clinical Signs, Symptoms or Conditions 122 122
No Consequences Or Impact To Patient 67 67
No Code Available 5 5
Insufficient Information 2 2
Misdiagnosis 2 2
Test Result 2 2

Recalls
Manufacturer Recall Class Date Posted
1 Beckman Coulter Inc. II Jun-02-2020
2 Beckman Coulter Inc. II Jun-28-2017
3 Roche Diagnostics Operations, Inc. II Mar-05-2020
4 Tosoh Bioscience Inc II Jun-05-2018
-
-